Nuveen’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-21,781
| Closed | -$222K | – | 3355 |
|
|
2025
Q1 | $222K | Hold |
21,781
| – | – | ﹤0.01% | 3110 |
|
|
2024
Q4 | $304K | Hold |
21,781
| – | – | ﹤0.01% | 3126 |
|
|
2024
Q3 | $425K | Sell |
21,781
-1,546
| -7% | -$29.5K | ﹤0.01% | 3058 |
|
|
2024
Q2 | $434K | Buy |
+23,327
| New | +$492K | ﹤0.01% | 3038 |
|
|
2023
Q2 | – | Sell |
-33,876
| Closed | -$357K | – | 3261 |
|
|
2023
Q1 | $357K | Sell |
33,876
-3,572
| -10% | -$108K | ﹤0.01% | 2881 |
|
|
2022
Q4 | $1.27M | Sell |
37,448
-5,714
| -13% | -$277K | ﹤0.01% | 2588 |
|
|
2022
Q3 | $2.07M | Sell |
43,162
-850
| -2% | -$50.6K | ﹤0.01% | 2381 |
|
|
2022
Q2 | $2.51M | Buy |
44,012
+13,361
| +44% | +$843K | ﹤0.01% | 2322 |
|
|
2022
Q1 | $2.62M | Sell |
30,651
-357
| -1% | -$52.8K | ﹤0.01% | 2383 |
|
|
2021
Q4 | $6.28M | Sell |
31,008
-1,638
| -5% | -$355K | ﹤0.01% | 1982 |
|
|
2021
Q3 | $8.79M | Sell |
32,646
-1,802
| -5% | -$433K | ﹤0.01% | 1870 |
|
|
2021
Q2 | $8.87M | Sell |
34,448
-272
| -0.8% | -$75.3K | ﹤0.01% | 1941 |
|
|
2021
Q1 | $10.4M | Sell |
34,720
-1,096
| -3% | -$341K | ﹤0.01% | 1772 |
|
|
2020
Q4 | $9.13M | Buy |
35,816
+179
| +0.5% | +$46.3K | ﹤0.01% | 1769 |
|
|
2020
Q3 | $8.87M | Sell |
35,637
-475
| -1% | -$149K | ﹤0.01% | 1594 |
|
|
2020
Q2 | $12.5M | Sell |
36,112
-2,486
| -6% | -$776K | 0.01% | 1331 |
|
|
2020
Q1 | $10.3M | Buy |
38,598
+16,005
| +71% | +$4.95M | 0.01% | 1269 |
|
|
2019
Q4 | $7.32M | Sell |
22,593
-13,230
| -37% | -$3.84M | ﹤0.01% | 1770 |
|
|
2019
Q3 | $9.79M | Sell |
35,823
-26,628
| -43% | -$9.77M | ﹤0.01% | 1587 |
|
|
2019
Q2 | $33.3M | Buy |
+62,451
| New | +$31.3M | 0.01% | 887 |
|
|
2018
Q4 | – | Sell |
-258
| Closed | -$235K | – | 1045 |
|
|
2018
Q3 | $235K | Buy |
+258
| New | +$220K | ﹤0.01% | 983 |
|
|
2018
Q2 | – | Sell |
-1,790
| Closed | -$2.85M | – | 1098 |
|
|
2018
Q1 | $2.85M | Buy |
1,790
+1,282
| +252% | +$1.65M | 0.02% | 555 |
|
|
2017
Q4 | $455K | Sell |
508
-15,063
| -97% | -$8.91M | ﹤0.01% | 915 |
|
|
2017
Q3 | $5.61M | Sell |
15,571
-6,603
| -30% | -$2.07M | 0.04% | 470 |
|
|
2017
Q2 | $6.5M | Buy |
+22,174
| New | +$6.41M | 0.04% | 478 |
|
|
2017
Q1 | – | Sell |
-674
| Closed | -$124K | – | 1443 |
|
|
2016
Q4 | $124K | Sell |
674
-16,126
| -96% | -$3.28M | ﹤0.01% | 1471 |
|
|
2016
Q3 | $4.33M | Buy |
+16,800
| New | +$4.33M | 0.03% | 559 |
|
|
2014
Q4 | – | Sell |
-8,683
| Closed | -$1.57M | – | 1644 |
|
|
2014
Q3 | $1.57M | Sell |
8,683
-1,467
| -14% | -$281K | 0.01% | 929 |
|
|
2014
Q2 | $1.95M | Sell |
10,150
-171
| -2% | -$30.2K | 0.01% | 827 |
|
|
2014
Q1 | $1.88M | Buy |
10,321
+5,725
| +125% | +$1.13M | 0.01% | 831 |
|
|
2013
Q4 | $782K | Sell |
4,596
-882
| -16% | -$142K | 0.01% | 1191 |
|
|
2013
Q3 | $858K | Buy |
+5,478
| New | +$1.01M | 0.01% | 1170 |
|
Other funds holding NKTR
NCM
TCM
Nuveen's NKTR Position: Q2 2025 in Review
Nuveen sold out of Nektar Therapeutics (NKTR) in Q2 2025, closing a stake of 21,781 shares — an estimated $222K sold.
Nuveen first reported a position in NKTR in Q3 2013 and held it in 32 quarters. The position peaked at $33.3M in Q2 2019. 109 funds tracked by Wall St. Rank hold NKTR as of Q2 2025.
- Nuveen reported no remaining Nektar Therapeutics position as of Q2 2025 after selling out during the quarter.
- Nuveen sold 21,781 Nektar Therapeutics shares in Q2 2025, an estimated $222K.
- Nuveen first reported a position in Nektar Therapeutics in Q3 2013 and held it in 32 quarters.
- Nuveen's Nektar Therapeutics position peaked at $33.3M in Q2 2019.
- 109 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q2 2025.
Based on Nuveen's 13F filing for Q2 2025, filed 12 Aug 2025.